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Background: The Major Histocompatibility Complex (MHC) is the most important genetic marker to study patterns
of adaptive genetic variation determining pathogen resistance and associated life history decisions. It is used in
many different research fields ranging from human medical, molecular evolutionary to functional biodiversity
studies. Correct assessment of the individual allelic diversity pattern and the underlying structural sequence
variation is the basic requirement to address the functional importance of MHC variability. Next-generation
sequencing (NGS) technologies are likely to replace traditional genotyping methods to a great extent in the near
future but first empirical studies strongly indicate the need for a rigorous quality control pipeline. Strict approaches
for data validation and allele calling to distinguish true alleles from artefacts are required.
Results: We developed the analytical methodology and validated a data processing procedure which can be
applied to any organism. It allows the separation of true alleles from artefacts and the evaluation of genotyping
reliability, which in addition to artefacts considers for the first time the possibility of allelic dropout due to
unbalanced amplification efficiencies across alleles. Finally, we developed a method to assess the confidence level
per genotype a-posteriori, which helps to decide which alleles and individuals should be included in any further
downstream analyses. The latter method could also be used for optimizing experiment designs in the future.
Conclusions: Combining our workflow with the study of amplification efficiency offers the chance for researchers
to evaluate enormous amounts of NGS-generated data in great detail, improving confidence over the downstream
analyses and subsequent applications.
Keywords: Major histocompatibility complex, Next-generation sequencing, 454 pyrosequencing, Molecular cloning,
PCR and sequencing artefacts, Amplification efficiency, Allelic dropout, Rodent, Delomys sublineatusBackground
The Major Histocompatibility Complex (MHC) is a
multigene family responsible for the adaptive immune
response in vertebrate hosts [1] and has become the
most preferred marker to study patterns of adaptive gen-
etic variation related to health issues and life history de-
cisions [2]. A hallmark of MHC genes is the high level
of polymorphism observed in most natural populations
caused by positive selection, gene duplication, recombin-
ation and gene conversion [3]. The variability in the
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reproduction in any medium, provided the orboth at the individual and population level, the excess of
heterozygosity, the sequence divergence between alleles,
as well as the number of locus duplications [1]. The num-
ber of MHC genes can differ greatly within and between
species, especially in the classical MHC genes, such as
class I and class II loci, probably due to their functional
importance in pathogen recognition [2,4].
The correct assessment of the individual allelic diversity
pattern and the underlying structural sequence variation is
the basic requirement to understand the functional import-
ance of MHC variability [5]. Multilocus MHC genes, how-
ever, pose great methodological challenges as inter-locus
sequence similarity usually prevents the development of
locus-specific primers. Thus, simultaneous amplificationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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often necessary e.g. [6-8].
Until recently, MHC genotyping was mainly done by
cloning/Sanger sequencing or in species with low copy
numbers by DNA-based methods using a gel matrix for
allele separation, such as single strand conformation poly-
morphism (SSCP), denaturing gradient gel electrophoresis
(DGGE) or reference strand-mediated conformational
analysis (RSCA) combined with PCR reamplification of
the separated bands (i.e. alleles) and Sanger sequencing.
PCR amplification of multi-allelic templates and molecular
cloning, however, have the disadvantage of a large error
rate due to the formation of chimeras, i.e. amplicons that
contain sequence motifs from two or more different al-
leles, and the formation of heteroduplexes, which become
mosaic sequences through the DNA mismatch repair sys-
tem during cloning [9,10]. As a consequence, gold stand-
ard rules to ascertain the assessment of correct levels of
individual diversity have been progressively developed.
These include simple modifications of PCR conditions,
use of replicates, i.e. several independent PCR amplifica-
tions per individual, and sequencing of a large number of
clones to reach allele saturation [10,11].
With the advent of next-generation sequencing (NGS)
technologies, such as 454 GS FLX Titanium pyro-
sequencing (hereafter 454), it becomes now feasible to infer
individual MHC allelic diversity with reasonable time as
well as cost balance for larger sample sizes. The new ap-
proach has recently been applied to different non-model
bird and mammal species with high copy number variation
[8,12-18]. However, artefacts are still expected to be fre-
quent. First of all, the error rate of 454 is not negligible, es-
pecially if the target sequence contains homopolymers
[19], which can lead to repetitive errors. Moreover, since
the sequencing of the targeted loci is still based on PCR
amplification, some of the errors will be similar to those
found in the traditional cloning/Sanger sequencing and
can originate during the first target-specific PCR or the
454 sequencing procedures due to polymerase nucleotide
misincorporation, chimera formation, or both. In particu-
lar, artefacts originating early in the process may be ampli-
fied across PCR cycles and therefore sequenced in multiple
copies, which makes them difficult to identify. Chimeras
may also be present in multiple copies, as they could be
formed independently many times from the same sources
during PCR cycles and resemble true alleles originating
in vivo through recombination [10].
Unnoticed artefacts can lead to overestimation of indi-
vidual allele numbers and overall diversity, crucial parame-
ters for subsequent analyses on the functional importance
of MHC diversity and the underlying selection processes.
Even though including replicates in the 454 study design
has been acknowledged as the most important source for
detecting analytical errors, the percentage of implementedreplicates in previous studies is null or rather low e.g.
[12,14,15]. Gold standard rules are still in the developmen-
tal process for NGS data. Therefore, a rigorous 454 quality
control is essential and strict approaches for data valid-
ation and allele calling are required to distinguish true al-
leles from artefacts [20,21].
Recently published studies e.g. [14-18] using 454 py-
rosequencing data followed and modified the quality
control and data validation protocols for MHC genotyp-
ing developed by Babik et al. [12], Galan et al. [13] and
Zagalska-Neubauer et al. [8]. Babik et al. [12] validated
variants on the basis of their frequency within individ-
uals and considered variants with an observed frequency
lower than a case-specific threshold as artefacts. They
also validated variants based on their dissimilarity with
the four most commonly found variants in a given sam-
ple and considered more distinct variants as more likely
to be true alleles. Their approach paid no attention to
the chimera problem, which are very dissimilar to both
parent variants and might occur at a non-negligible fre-
quency within individuals [13]. Galan et al. [13] devel-
oped a probabilistic model for determining the read
coverage threshold T1 (minimum number of sequences
per individual required for reliable genotyping) for valid-
ating individual genotypes at a given confidence level.
Furthermore, Galan et al. [13] used a second threshold
T2 (minimum frequency of a variant within an individ-
ual) for the minimum coverage required to define a vari-
ant as a true allele. Galan’s approach also considered the
chimera problem and these artefacts were discarded
after sequence alignment and BLAST procedures.
Zagalska-Neubauer et al. [8] procedures included T1 as
described in Galan et al. [13], but did not establish a sec-
ond threshold for separating true alleles from artefacts.
Instead, variants were accepted if they were present in at
least two amplicons with a minimum of three reads (2-
PCRs-3-copies-in-each rule) and were further checked
for the possibility of representing artificial chimeras.
Overall, the three analytical methods described above
have several differences in their allele calling approaches
but share at least two general assumptions: artificial se-
quences should be less frequent than true alleles; and ar-
tefacts should have their sources in the true alleles (e.g.
chimeras and single base pair mismatches). They also
mentioned that primers might have different specificity
to different variants, but their analyses did not take
differences in PCR amplification efficiency into account,
i.e. differences in the probability that an allele is ampli-
fied due to primer mismatches. Ignoring differences in
allele amplification efficiencies might have a significant
effect on the read coverage required for reliable genotyp-
ing that is crucial for all subsequent downstream ana-
lyses and might cause an allelic dropout. Allelic dropout,
i.e. alleles that are not detected in all individuals that
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increase in the homozygosity values. Wrong genotypes
and inflated homozygosities can bias the analysis of se-
lection mechanisms in host-pathogen interactions and
life history decisions such as mate choice, phenotype-
genotype associations, recombination level, intra and
inter-population differentiation, and associated conser-
vation management decisions e.g. [10,22,23].
Here, we used 454 GS FLX Titanium pyrosequencing
data from a wild rodent with high copy number vari-
ation in the MHC class II DRB locus to develop an allele
calling workflow that can be transferred to any other
non-model organism. Furthermore, we compared the re-
sults obtained by high-throughput pyrosequencing with
the standard cloning/Sanger sequencing in all of our
samples. Our workflow builds up on previous data pro-
cessing and validation procedures [8,12,13], but has been
considerably improved to identify mismatches occurring
during the first PCR, the presence of chimeras, and the
possibility of allelic dropout. It requires two amplicon
replicates for all individuals, which allows the beginning
of the classification procedure to be performed for each
individual independently. Our approach presents two
major differences to the three mentioned previous stud-
ies [8,12,13]. First, our method evaluates and classifies
independently each single variant as either allele or arte-
fact. Moreover, even though we also assume that arte-
facts are in general less frequent than true alleles, we do
not rely on an arbitrary threshold to separate alleles
from artefacts, in contrast to Babik et al. [12] and Galan
et al. [13]. Unlike Zagalska-Neubauer et al. [8], we also
do not make the strong assumption that identical vari-
ants should have one single classification. The second
major difference to previous approaches is our a-
posteriori analysis. We studied how differential allele
amplification efficiencies influence the confidence level
of genotypes and proposed, accordingly, a new way of
estimating the minimum number of sequences per indi-
vidual required for reliable genotyping. Moreover, we de-
veloped a method to assess the confidence level of
genotyping a-posteriori per genotype, which helps to de-
cide which alleles and individuals should be included in
any further downstream analyses.
Results
Analysis of putative alleles and artefacts within the
454 dataset
We included all 40 individuals subjected to cloning/Sanger
sequencing in duplicates (amplicon replicates) in one re-
gion (1/8th) of a 454 FLX Titanium picotiter plate. All 80
amplicons were barcoded (Additional file 1: Figure S1). All
terms used to describe the subsequent results are outlined
in Table 1. We obtained 86,153 sequence reads passing
the filters of the GS Run Processor (Figure 1). 81,309 readshad the correct length with recognizable f-and r-MIDs,
from which read numbers per amplicon ranged from 311
to 2276 (1028 ± 387) and from 1187 to 3193 per individual
(summing both amplicon replicates). A total of 63,166
(73.3%) reads passed the initial filtering steps by showing
the expected read length, complete primer sequences, high
quality and no frameshifts (Figure 1).
We obtained reliable data for 36 out of the 40 individ-
uals with 454 sequencing. Incongruencies between the
two intra-individual amplicon replicates were detected
for three individuals, probably due to either DNA cross-
contamination or unnoticed exchange of barcodes before
the first amplification. A fourth individual presented too
few reads for one of the amplicons (20 reads after our
filtering steps), even though we had targeted a very high
number of reads per amplicon (>1000 in average). We
removed these four individuals from subsequent analysis.
For the remaining 36 individuals the number of reads after
applying our initial data filtering (Figure 1) had an average
per amplicon of 768 ± 314, ranging from 142 to 1600 reads
per amplicon and from 291 to 2345 per individual.
The subsequent workflow (Figure 2) allowed us to dis-
tinguish most of the filtered reads (63,091 out of 63,166
reads, 99.88%) into ‘putative artefacts’ (33,400 or ~53% of
filtered reads) or ‘putative alleles’ (29,691 or ~47% of fil-
tered reads). The remaining 75 reads were marked as ‘un-
classified variants’, as they did not fulfil all assumptions to
be called a ‘putative allele’ but could not be classified as
‘putative artefacts’. We checked the classification of each
‘unclassified variant’ among amplicons and detected three
variants classified in at least one amplicon as a ‘putative al-
lele’, but that were more often defined as ‘unclassified vari-
ant’ because of either lower frequency compared to
‘putative artefacts’ or absence in one individual’s amplicon
replicate. The frequency inconsistencies of the latter vari-
ants suggest lower amplification efficiency when compared
to other alleles. The presence of all three variants could be
confirmed by Sanger sequencing after designing new
allele-specific primers. We accepted those three variants
as true alleles, but labelled them as ‘putative low efficiency
alleles’. Those three alleles corresponded to two additional
amino acid sequences (Desu-DRB*009, Desu-DRB*053).
We found a total of 64 unique nucleotide true MHC vari-
ants, which translated into 57 putative MHC alleles on the
amino acid level (Additional file 1: Figure S2). The ‘puta-
tive alleles’ were called MHC alleles for simplicity even
though it was not possible to assign them to a particular
locus. The alleles were denominated as Desu-DRB*X,
where X corresponds to an allele number between 01 and
124 (GenBank under accession No’s KF134719-KF134782)
according to the nomenclature (Klein et al. 1990). Without
‘putative low efficiency alleles’ between two and nine (5.4 ±
1.5) alleles were detected per individual, suggesting
at least 5 copies of DRB in Delomys sublineatus. If the
Table 1 Definition of terms used
Term used Definition
Reads Sequences passing quality filtering criteria according to the standard amplicon pipeline from Genome Sequencer
FLX System Software
Cluster Set of identical reads within an amplicon
Variant Specific sequence of a cluster
Putative artefact Sequences or variants that are believed to result from polymerase or sequencing errors
Chimera Reads containing sequence motifs from two different putative alleles
Putative allele Variants that are believed to represent true alleles at the end of the allele and artefact identification workflow (Figure 2)
Amplification efficiency Relative frequency at which an allele is amplified for a given primer pair
Allelic dropout Alleles that are not detected in individuals that biologically possess those alleles
1-2 bp diff 1-2 base pair (bp) differences to the most similar variant with a higher frequency within an amplicon
>2 bp diff >2 bp differences to the most similar variant with a higher frequency within an amplicon
ALL READS
after passing filters of GS Run Processor  
Remove reads shorter than expected length
(f-MID+f-primer+target+r-primer+r-MID < 250bp)
Select reads with complete MIDs
Assign reads to corresponding
f+r-MID combination
Remove reads with incorrect
primer sequences
Remove reads with > 5% low quality 
(Phred score < 20)
Select reads with expected protein reading frame
(target sequence of 229 bp N x 3bp)
86153
85679 (99.45%)           474 





for subsequent allele and artifact
identification workflow
Figure 1 454 reads filtering: pyrosequencing data quality
assessment. Pathway illustrating initial filtering steps to ensure data
quality of reads obtained by 454 pyrosequencing and to facilitate the
subsequent allele and artefact identification workflow. The number of
reads included in a filtering step is indicated on the left of each arrow
and the percentage of the initial number of reads in brackets. The
number of discarded reads is shown on the right of each arrow.
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range of alleles detected by 454 pyrosequencing increases
to 3-11 per individual (Figure 3).
The variant frequencies within each amplicon (i.e. clus-
ter frequencies) were analysed based on their classification
categories of Figure 2. Figure 4 shows the prevalence of ar-
tefacts over alleles in the total number of clusters (artefac-
tual clusters: 3674; putative allele clusters: 390). Although
we confirmed only between 2-9 (3-11) alleles per individ-
ual (Figure 3), the number of variants varied between 6
and 126 (57 ± 26) per amplicon. The intra-amplicon classi-
fication for ‘putative artefacts’ was clearly dominated by
'chimeras' (37.7 ± 22.3) followed by ‘1-2 bp diff ' (9.7 ±
10.5) and ' > 2 bp diff ’ (3.7 ± 3) (see Table 1 for definitions).
The most frequent variant classified as ‘putative artefact’
represented 5.4% of an amplicon and the least frequent
variant among the ‘putative alleles’ represented only 1.5%
of the total amount of reads within an amplicon (after ex-
cluding all intra-amplicon singletons).
Comparison of individual MHC variability detected by 454
pyrosequencing to cloning/Sanger sequencing
In the 36 individuals investigated by both genotyping
approaches, we detected 52 MHC alleles on the nucleo-
tide level by conventional cloning/Sanger sequencing
which could be considered as true MHC alleles ac-
cording to the widely accepted standards in the litera-
ture. They corresponded to 49 unique amino acid
sequences (Additional file 1: Figure S2). The average
number of alleles per individual was 4.25 ± 1.34, and
ranged from two to eight, corresponding to at least four
DRB loci.
All alleles detected by cloning/Sanger sequencing were
also detected by 454 pyrosequencing (Additional file 1:
Figure S3) and showed a similar sequence variability pat-
tern between the two methodologies, both at the nucleo-
tide and amino acid levels (Additional file 2: Table S1).
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Figure 2 Allele and artefact identification workflow: pathway for identification of artefacts and putative alleles. Read numbers are given in
bold, number of clusters are indicated in italics and the number of putative alleles is underlined. Note that putative alleles might be identified at
different steps depending on the individual, explaining why the sum is larger than the total number of putative alleles observed in this study.
Dashed gray rectangles indicate intra-amplicon cluster classifications (‘chimera’, ‘1-2 bp diff’, ‘> 2 bp diff’). Final cluster identification is highlighted in
red. Unclassified variants1 include those neither classified as ‘putative artefacts’ nor as ‘putative alleles’ because they either appeared in a single
amplicon or their frequencies were not above all artefacts. A detailed description of the workflow steps (I to III) is provided in the Method section.
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the 36 individuals when compared to cloning results
(Figure 3, Additional file 1: Figure S4). In addition, on the
intra-individual level, 454 results indicate a significantly
higher number of alleles than conventional cloning/Sanger
sequencing (Figure 3, cloning: mean = 4.25 ± 1.34; 454-
pyrosequencing: mean = 5.92 ± 1.65; Wilcoxon paired
test: P < 0.001, N = 36), even though the number of al-

























Figure 3 Differences in the individual number of alleles detected
by cloning/Sanger (blue bars) and 454 pyrosequencing (red bars).correlated to the ones obtained by cloning/Sanger se-
quencing (Additional file 1: Figure S4, rho = + 0.78, P <
0.001, N = 36).
Allele amplification efficiencies
We used a maximum likelihood approach to estimate the
amplification efficiency of each allele (see Methods) and
found that there is a substantial variation in the ampli-
fication efficiency among alleles (Figure 5). The lowest
amplification efficiency was reached for the allele Desu-
DRB*028, which presented an amplification efficiency of
0.19, i.e. more than five times lower than the allele Desu-
DRB*001 used as a reference (amplification efficiency = 1)
(Additional file 2: Table S2). Maximum amplification effi-
ciency was reached for the allele Desu-DRB*091, which
with an efficiency of 2.40 is more than 12 times more effi-
cient than Desu-DRB*028. No other allele presented an
amplification efficiency close or equal to two, suggesting
that Desu-DRB*091 was the only one corresponding to
either a duplicated allele in different loci or a homozygous
locus. This allele was present in four individuals always
as the most frequent one (Cluster1) (Additional file 2:
Table S2), and the ratio in frequency compared to the sec-
ond most frequent cluster (Cluster2) ranged in average




















































































































Putative allele with low efficiency
Putative allele
Unclassified variant
Putative artifact (from >2 diff intermediate category)
Putative artifact (from 1-2 diff intermediate category)



















Variant frequency (%) within each amplicon
Figure 4 Frequency distribution for all final cluster (= variant) classifications. The cluster frequencies within their respective amplicons are
indicated based on the final classification categories after the allele and artefact identification workflow. The frequencies on the x axis represent the
proportion of reads within an amplicon (i.e. intra-amplicon frequency) that represent a given variant or cluster, while the y axis shows the total number
of clusters over all amplicons for each intra-amplicon frequency range. The grey zone indicates the overlapping zone of artefacts and putative alleles,
i.e. the zone between the most frequent variant classified as ‘putative artefact’ and the least frequent variant among the ‘putative alleles’ within an
amplicon. The dotted line at 4.37% represents the threshold T2 according to Galan et al. [13] to separate putative alleles from putative artefacts. The
most frequent artefact within an amplicon represented 5.4% of the total number of reads of this specific amplicon.
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Even when omitting Desu-DRB*091, the span in efficiency
between alleles represented an 8-fold increase between the
least and the most efficient alleles.
Effect of variation in amplification efficiency on threshold T1
The threshold T1 suggested by Galan et al. [13] (T1Galan
Negmult, Table 2) aims to estimate the minimum number
of reads necessary to obtain a reliable genotyping. Since
Galan et al. [13] assumed that all alleles have the same
amplification efficiency, we studied how T1 would be af-
fected when taking variation in amplification efficiencies
into account. To do so, we first developed a simulation
procedure (T1Galan Simul) less computationally intensive
but still highly comparable to T1Galan Negmult. T1Galan
Simul estimations and T1Galan Negmult differed by less than
one read on average and the biggest departure observed
was three reads in the case where the presence of nine
alleles was considered, which represents a relative error
of only 3% (cf. last row in Table 2). The gain in comput-
ing time was substantial. For example, our simulationapproach allowed us to obtain an accurate estimate of
T1Galan Simul for the case of nine alleles in less than three
minutes using the easy but slow programming language
R, while the efficient implementation programmed by
Galan et al. [13] in the much faster language C++ re-
quires several hours to provide a similar value.
The new T1 values obtained assuming different ampli-
fication efficiencies (T1Simul VarAmplEff, Table 2) showed
that taking variation in amplification efficiency into ac-
count leads to an increase of T1 by 1.03 to 4.06 fold
(mean = 1.61) in order to maintain the same confidence
level of genotyping. The highest sensitivity to the as-
sumption of equal amplification efficiency concerned the
genotype of individual GO3120, which consists of five
alleles: the T1 value shifts from 50 to 203 when Galan’s
assumption of equal amplification efficiency was relaxed.
Interestingly, this genotype includes the allele Desu-
DRB*028, which is the one with the lowest estimated amp-
lification efficiency (Table 2, Additional file 2: Table S2).
Subsequently, we further relaxed the assumption that

































































































































































































































































Figure 5 Standardised allele amplification efficiency. The amplification efficiency is estimated for each ‘putative allele’ by maximum likelihood
and represented by a blue dot. Each dot is connected by a vertical line to the full horizontal line representing efficiency 1.0, which was defined using
the first allele (Desu-DRB*001) as a reference (see text for details). The dashed horizontal line represents an efficiency of two, which could represent
duplicated or homozygous alleles. ‘Low efficiency putative alleles’ are not represented (Desu-DRB*009a, Desu-DRB*053b, Desu-DRB*053c).
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any given amplicon. Under these circumstances, T1 values
(called T1Resampled), were between 0.93 and 6.28 fold
(mean = 1.76) higher than T1Galan Simul and between 0.76
and 2.76 fold (mean = 1.28) higher than T1Simul VarAmplEff
(Table 2). T1Resampled increased with the number of alleles
observed, as predicted by Galan et al. for T1Galan Negmult.
Nonetheless, knowing only the number of alleles seems
not to be sufficient to predict T1 accurately (Figure 6A;
Spearman rank correlation between T1Galan Simul and
T1Resampled, rho = + 0.54, P < 0.001, N = 36). Figure 6B
shows however that with the knowledge of the lowest ob-
served read frequency present in a genotype, one could al-
most predict T1Resampled to perfection (rho = − 0.996, P <
0.001, N = 36). Interestingly, the lowest read frequency can
be predicted accurately (rho = + 0.79, P < 0.001, N = 36)
from the ratio between the lowest allele amplification effi-
ciency and the sum of amplification efficiency across all al-
leles constituting one genotype. Thus, we found that in
our system T1Resampled values can be predicted accurately
from the lowest efficiency within a genotype (rho = − 0.80,
P < 0.001, N = 36).
Therefore, we performed simulations to estimate T1
according to different values of the minimum amplificationefficiency across all alleles (T1Min Amp Eff, Additional file 2:
Tables S3 and S4). Additional file 1: Figures S5 and S6
show that T1Min Amp Eff increases linearly with the number
of alleles for a given value of minimum amplification effi-
ciency considered. The results hold for T1Galan Negmult (as-
suming an equal amplification efficiency of 1.0), as well as
for any other value of minimum efficiency.
Discussion
Although benefits of using NGS technologies in sequen-
cing multilocus and highly variable regions such as the
MHC are undeniable, these novel approaches are not ex-
empt from biases and errors. While the recent literature
puts emphasis on mistakes that can occur during the se-
quencing process, it is important to realize that long last-
ing limitations concerning genotyping can also occur
because, similarly to the traditional cloning/Sanger se-
quencing procedure, NGS genotyping approaches are still
based on amplification of the targeted locus via PCR. We
showed that the diversity of artefacts emerging during the
PCR step can largely outnumber variants corresponding
to true alleles (in our study: artificial variants: 3674; puta-
tive allele variants: 390), and that the total number of se-
quence reads originating from artefacts can be higher than
Table 2 T1 thresholds
# Reads1 # Reads2 # Alleles T1Galan Negmult T1Galan Simul T1Simul VarAmplEff T1Res1 T1Res2
ID 1186 306 5 50 50 74 62 66
102 418 326 6 62 61 92 176 64
153 329 205 6 62 61 93 111 121
161 416 382 4 38 38 77 113 80
165 252 524 5 50 50 128 240 137
190 295 418 6 62 61 138 102 139
211 285 443 4 38 38 63 155 69
215 506 829 6 62 61 64 64 59
223 410 335 5 50 50 100 88 87
225 458 383 4 38 38 58 53 52
248 239 463 6 62 61 68 67 71
252 536 549 5 50 50 73 61 65
256 409 297 5 50 50 74 117 93
266 341 342 5 50 50 86 105 57
272 317 317 5 50 50 53 53 69
281 430 324 7 75 74 120 111 177
347 171 261 6 62 61 83 96 73
430 300 288 4 38 38 62 57 43
449 545 283 4 38 38 82 91 75
492 133 1043 2 15 15 16 18 15
493 232 221 5 50 50 65 114 88
4695 361 701 6 62 61 113 142 120
4787 71 78 3 27 27 56 42 50
5092 273 535 6 62 61 98 75 111
5116 202 378 6 62 61 69 63 77
C3659 254 496 4 38 38 55 50 45
GO3120 220 456 5 50 50 203 93 314
GO3131 346 618 8 87 85 124 87 98
GO3132 511 794 4 38 38 51 54 53
GO3133 281 453 7 75 74 124 78 94
GO3134 363 678 8 87 85 124 102 342
GO3382 492 776 8 87 85 153 150 257
GO3394 482 609 3 27 27 28 25 25
GO3899 322 506 7 75 74 81 87 95
GO3922 235 359 6 62 61 75 68 136
GO3957 440 654 9 100 97 120 101 104
The threshold T1 defined as the minimum number of sequences per individual required for reliable genotyping was computed by Galan et al. [13] using a
negative multinomial distribution (referred as T1Galan Negmult). We approximated the threshold by a much less computationally intensive simulation approach
(T1Galan Simul). T1Galan Negmult und T1Galan Simul do not take differences in allele amplification efficiencies into account. We used a simulation approach to investigate
the effect of variation in amplification efficiency between alleles on the minimum number of reads required to achieve a reliable genotyping (T1Simul VarAmplEff).
Assuming that we oversampled each amplicon, we estimated what would have been the minimum number of reads that would have given us the same
genotypes as obtained with our 454 data for the two amplicon replicates per individual by resampling (T1Res1, T1Res2).
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http://www.biomedcentral.com/1471-2164/14/542for true alleles. In addition, we demonstrated that PCR
may be also responsible for allelic dropout caused by dif-
ferential amplification efficiency between alleles. These
two PCR-related side effects can lead to importantmistakes at the level of allele calling and/or genotyping
and therefore significantly alter downstream analyses rely-
ing on heterozygosity, allelic diversity, and genotype com-
position. The limitations caused both by PCR biases and




























Figure 6 Influence of the individual number of alleles (A), and the lowest read frequency (B) on the minimum number of reads
required to determine a complete genotype with a 99.9% confidence level. Each point represents a different individual (N = 36). The
minimum number of reads required was a posteriori computed (T1Resampled) by resampling both amplicon replicates (T1Resampled1, T1Resampled2)
and the maximal value was retained. The dashed line in (A) illustrates T1Galan Simul computed according to Galan’s et al. [13] definition of an
allele’s dropout (i.e. an allele associated with two reads or less; see text for details).
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NGS-based analyses: 1) the separation of true alleles from
artefacts and 2) the correct evaluation of the reliability of
genotypes obtained after allele calling, which should in
addition to artefacts consider the possibility of allelic drop-
out. The methodology introduced in this study was specif-
ically designed to address these problems.
Separation of true alleles from artefacts
As shown in other MHC genotyping studies using 454
pyrosequencing e.g. [12,13], many of the variants obtained
originate from artefacts. Artefacts may be produced by 454
pyrosequencing methodology during four different stages:
the initial specific PCR, the emPCR, the sequencing reac-
tion and signal processing. Although the use of an initial
data quality check and reads filtering step (Figure 1) elimi-
nates a great amount of them, a potentially large number
of artefacts is still expected to remain, including many
present in multiple copies within amplicons (in our study:
total number of filtered reads: 63,166; artefacts: 33,400; ar-
tefacts occurring in multiple reads: 11,685,=18.2% of the
filtered reads, Figure 2).
Our workflow was specifically designed to deal with
the different kinds of artefacts potentially present.
Homopolymer-associated errors along with other causes
of insertion and deletion errors (i.e. indels) are the most
common errors associated with 454 pyrosequencing base
calling (i.e. sequencing signal processing). This type of
error is identified and removed during our initial filtering
steps, which eliminate reads with shifts in the reading
frame. Chimeras caused by PCR artefact formation are the
most frequent kind of artefact among the filtered reads
and may be hard to detect because they usually resemble
true recombining alleles [10]. However, we eliminatedthem by assuming that artefactual chimeras will be always
present together with their sources (frequently true alleles)
and in lower frequency. The basis for such assumption lies
on the fact that chimera formation is thought to occur
mainly on the last cycles of a PCR programme and would
therefore be amplified less often than true alleles [10]. Ar-
tefacts can also originate from mismatches caused by poly-
merase errors during emPCR, which are eliminated to a
large extent by deleting all singletons within amplicons.
This kind of artefact usually corresponds to singletons be-
cause the probability that the same mismatch occurs inde-
pendently in different reads should be extremely low [13],
especially before position 400 bp of a 454-generated se-
quence [19]. Importantly, our workflow also allows the
identification of mismatches caused by polymerase errors
produced during library preparation (initial specific PCR)
because individual amplicons were done in independent
duplicates. While the probability of the same error occur-
ring more than once during the initial specific PCR remains
very low, implemented errors can be highly amplified when
they occur in early PCR cycles [10] and the same amplified
mistake can potentially be observed in multiple copies per
amplicon. Therefore only the comparison of amplicon rep-
licates allows the detection of polymerase errors.
The comparison of variants classification by our work-
flow to the ones obtained with alternative methods dem-
onstrates that our method increases both the power (i.e.
less false-negatives) and the robustness (i.e. less false-
positives) of allelic assignments, as exemplified below.
First, if we used the threshold T2 proposed by Galan et al.
[13] to separate putative alleles from putative artefacts, all
the different putative alleles defined by our allele and arte-
fact identification workflow would still be recognized, but
not for all individuals that carry them (i.e. false negatives).
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to the upper end of the artefact cluster frequency distribu-
tion within amplicons (Figure 4). The use of T2 would
change the genotype composition for 12 individuals, with
a total of 17 variants that would fail to be called ‘putative
alleles’. In addition, ‘low efficiency putative alleles’ would
be accepted for only two out of the 14 individuals we
detected carrying this kind of allele.
Second, using the procedure suggested by Zagalska-
Neubauer et al. [8], who accepted variants if they were
present in at least two amplicons with a minimum of three
reads (2-PCRs-3-copies-in-each rule), we would recognize
all ‘putative alleles’ as well as our ‘low frequency putative
alleles’ for all individuals, but their method would lead to
erroneously consider as new ‘putative alleles’ two ‘putative
artefacts’ and three ‘unclassified variants’ according to our
classification (false positives). In addition, their method
would fail to distinguish two ‘putative artefacts’ and two
‘unclassified variants’ that have identical sequences to true
alleles in other individuals. We trust our classification be-
cause those specific variants were found either in low fre-
quencies and/or were present in only one of an individual
replicates. Finally, if we used a single amplicon for each in-
dividual like in their original approach, we would have im-
mediately discarded 20 alleles that we detected in a single
individual only.
Overall, distinguishing between true alleles and artefacts
has been possible because our workflow combines several
key features: First, using amplicon replicates for each indi-
vidual facilitates variant classification and helps to re-
cognize mistakes during laboratory procedures, which are
more likely to occur with increasing numbers of
multiplexed samples. Moreover, amplicon replicates help
with the identification of alleles that are inconsistently
amplified (allelic dropout) by a given primer pair. Second,
our workflow does not rely on pre-defined thresholds
based on intra-amplicon variant frequencies for identifica-
tion of true alleles (such as T2), which could create a bias
in allele calling by not detecting alleles with low or incon-
sistent intra-amplicon frequencies. Third, our workflow
allows the identification of alleles with low amplification
efficiency, indicating whether primers should be re-
designed in order to cover these alleles/loci. Finally, our
reads filtering pathway (Figure 1) and our allele and
artefact identification workflow (Figure 2) can be ad-
justed to different needs in forthcoming MHC studies
(see Additional file 3: Text S1).
Comparison of individual MHC variability detected by 454
with cloning/Sanger sequencing
NGS technologies are likely to replace cloning and Sanger
sequencing for MHC genotyping to a great extent in the
near future. Nevertheless, traditional MHC genotyping ap-
proaches may remain an alternative to consider when alimited amount of samples is to be genotyped, as NGS is
still expensive and many research groups do not have dir-
ect access to these technologies. Few studies compared
the performance of one of the traditional methods with
the outcome using a 454 approach using identical individ-
uals [15,16]. However, this knowledge is essential to cali-
brate past and future findings. Our study has shown that
results of 454 pyrosequencing and traditional cloning/
Sanger sequencing are highly comparable at the qualitative
level, but the NGS allowed us to detect a higher number
of ‘putative alleles’. Additional comparative studies will
shed light on whether this discrepancy between NGS and
traditional methods is general or species-specific, and
whether it is more pronounced in species with high copy
numbers or not. We believe the higher allele detection
probability of NGS builds on the higher sequencing depth
that users are able to choose, rather than a real limitation
of the traditional method. Consequently, cloning/Sanger
sequencing could be used to supplement NGS studies, as
long as the same T1 and allele calling workflow are used
for both methods.
Importance of allelic dropout: amplification efficiencies
and confidence level of genotyping
Allelic dropout is an important source of bias and errors in
allele calling or genotyping. The analysis of the relationship
between allele amplification efficiency and the confidence
level of genotyping (performed on variants classified as ‘pu-
tative alleles’) suggests that allelic dropout is a consequence
of the low efficiency of certain alleles. Our workflow
allowed us to identify three alleles (those classified as ‘low
efficiency putative alleles’) very likely to undergo allelic
dropout. Indeed, these alleles did not show a consistent
frequency among the amplicons in all individuals that seem
to carry these variants, were generally associated with
low number of reads, and for a number of individuals
these alleles were completely absent in one of the
amplicon replicates.
We showed that low amplification efficiency does not
only concern few alleles, but that many have amplification
efficiencies lower than optimal. By assuming all alleles to
have the same efficiency, the effective genotyping coverage
obtained when following Galan et al.’s T1 recommenda-
tion becomes insufficient. Although we targeted an un-
usually high coverage and obtained numbers of reads
much higher than Galan et al.’s recommendations, one
‘putative allele’ was still likely to be involved in allelic
dropout. This allele was easily identified using our
resampling-based method (the total number of reads did
not meet our T1Resampled for all amplicons presenting this
allele). As we showed that the confidence level of genotyp-
ing was mainly constrained by the lowest read frequency
among the alleles constituting the genotype of an individ-
ual, the problematic allele was logically the allele with the
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(Desu-DRB*028, standardised efficiency: 0.19). Conse-
quently, this allele should not be included in the genotypes
for downstream analysis because it is likely to suffer from
allelic dropout in some individuals. Capturing the second
least efficient allele (Desu-DRB*074) instead requires a
number of reads that we obtained for all but two amplicon
replicates. Nonetheless, these two problematic amplicons
were associated with replicates that did reach the adequate
T1 threshold value and did not include allele Desu-
DRB*074, therefore eliminating chances of allelic dropout.
Consequently, this second least efficient allele was reliably
covered and could be included in further analysis using
these individuals’ genotypes, as well as all alleles with a
greater amplification efficiency value.
Overall, while our methodology successfully revealed in-
stances of allelic dropout, differences in the expected
number of loci found among individuals (one to five loci if
we consider ‘putative alleles’ only, and two to six loci if we
also consider the ‘low efficiency putative alleles’), suggests
that other instances of allelic dropout have remained un-
noticed. Therefore, it is likely that other alleles were com-
pletely missed during the first amplification unless this is
explained by a variable number of MHC DRB loci within
the same population [4].
A guideline to plan future experiments can be derived
from the expected maximum number of alleles and the
minimum amplification efficiency one could accept (e.g.
10 alleles and a minimum standardised amplification effi-
ciency of 0.3). From these two numbers, information pro-
vided by Additional file 1: Figures S5 and S6 and
Additional file 2: Tables S3 and S4 allow one to directly
obtain the number of reads per amplicon required to
reach 99.9% confidence level of genotyping. Note that be-
cause of the linearity of the relationship between T1 and
the number of alleles (Additional file 1: Figures S5 and
S6), one can derive graphically guidelines for higher num-
ber of alleles without any computational work. Import-
antly, the required number of reads per amplicon
suggested by this method only provides guidance, but does
not replace the coverage analysis based on resampling that
has to be performed a-posteriori. This is because during
the a-priori planning of a NGS project it is not possible to
know the amplification efficiency across all alleles and we
therefore assumed amplification efficiency to be optimal
for all but the least efficient allele. Strong departure from
this assumption may happen in certain system. Besides,
the number of reads estimated to reach a certain confi-
dence level of genotyping refers to reads that represent
‘putative alleles’ at the end of our workflow (i.e. after ex-
cluding all artefacts). In this study, we originally obtained
86,153 high quality reads from 1/8th of a 454 picotiter
plate, and our final numbers after the initial filtering steps
and having excluded artefacts included 29,691 reads whichrepresented alleles, i.e. around one third of the initial reads.
Estimating the required sequencing coverage per amplicon
a-priori should probably consider similar high percentages
of low quality reads and artefacts, or the possibility of in-
creasing the coverage whenever necessary, and the coverage
analysis based on resampling has to be performed a-
posteriori after collecting the data in any case.
Conclusions
Genotyping studies of multilocus MHC genes using
NGS are prone to inaccurate allele-calling caused by
both artefacts and unnoticed allelic dropout, especially
due to the lack of matured approaches to deal with large
amounts of data with an unknown level of complexity.
At the same time, the correct assessment of an individ-
ual’s MHC constitution is the most fundamental pre-
requirement to address the functional importance of
MHC allelic diversity in evolutionary ecology, pathogen
resistance and conservation. Our work, which builds on
previous studies such as Babik et al. [12], Galan et al.
[13] and Zagalska-Neubauer et al. [8], allows an efficient
and robust evaluation of the allelic and genotyping
coverage associated with a given set of primers. One of
the crucial steps in our proposed workflow is the ampli-
fication of independent replicates for each individual,
which overcomes some flaws from previous approaches,
such as the misidentification of artificial sequences as
true alleles, and the non-identification of allelic dropout
and alleles with amplification deficiencies. Another cru-
cial feature of our methodology is the consideration of
allelic dropout via the measurement of the allele amplifi-
cation efficiency. By ignoring variation in allele amplifi-
cation efficiency, previous methodologies overestimated
the confidence level of genotyping. In addition, we
showed that amplification efficiencies can be used to es-
timate the minimum number of reads required for geno-
typing. Allelic dropout cannot be avoided easily but it
does not represent a major problem as long as alleles/
loci that might be affected by this phenomenon are iden-
tified and removed from the downstream analysis when-
ever appropriate. Combining our workflow with the
study of the impact of differences in amplification effi-
ciency offers the chance for researchers to evaluate and
understand data generated by NGS in great detail, im-
proving confidence over the approach as well as the
follow-up analyses and subsequent applications.
Methods
Ethics statement for field work and collecting DNA
samples
For the present study, we used 40 unrelated samples of the
Pallid Atlantic Forest Rat Delomys sublineatus (Thomas,
1903), an endemic species in the Brazilian coastal rainfor-
est Mata Atlantica. This rodent is used as an indicator
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lected due to its high copy number variation in MHC class
II DRB loci and relevance for further immuno-ecological
studies [32-34]. Trapping, animal handling and collection
of tissue samples for this project complied with inter-
national guidelines and were approved and permitted by
the national authority, the Instituto Brasileiro do Meio
Ambiente e dos Recursos Naturais Renováveis-IBAMA
(permission 11573-2) and conformed to guidelines sanc-
tioned by the American Society of Mammalogists Animal
Care and Use Committee [35]. Because our study did not
involve any experimentation (e.g. maintenance in captivity,
injection of drugs, or surgery) an approval from the Ethics
Committee of the Institute of Biosciences, University of São
Paulo (Comissão de Ética em Uso de Animais Vertebrados
em Experimentação, CEA, http://ib.usp.br/etica_animais.
htm) was not required.
Traditional approach: molecular cloning followed by
Sanger sequencing
Genomic DNA was extracted from ear tissue using the
GEN-ial all tissue kit (GEN-IAL GmbH, Troisdorf,
Germany) following the manufacturer’s instructions. We
examined a 228 bp fragment of MHC class II DRB exon2
coding for the major part of the functional important
antigen-binding sites of the β1 domain. The targeted frag-
ment was amplified in all individuals (N = 40) using the
primer pair JF8-iV (f-primer: 5'-TGGACGAGCAAGAC
GTTCCTGT-3') and Tub2JF (r-primer: 5'- CGAYCCC
GWAGTTGTGTCTGCA-3'). The primers fit to usually
highly conserved parts of MHC class II exon2 across
mammals. The forward primer has been designed to
optimize specificity to Delomys sublineatus. Extensive
testing of different primer combinations have been car-
ried out at the beginning of the project to design the
best primers possible. To minimize misincorporation
errors, PCR products were generated with a proofread-
ing polymerase (HotStar HiFidelity polymerase, Qiagen,
Hilden, Germany). Two independent PCRs for cloning
were performed per individual and the outcome was
considered as congruent if the identical number and se-
quence pattern of variants were detected by subsequent
Sanger sequencing.
PCR was conducted in a total reaction volume of 20 μl
including 200 ng DNA, 0.75 μM of each primer (Sigma-
Aldrich, Steinheim, Germany), 5× HotStar HiFidelity
PCR buffer (including dNTPs and MgSO4) and 0.5 unit
of Taq polymerase. Thermocycling comprised an initial
denaturation step at 96°C for 10 min, followed by 33 cy-
cles of 1 min denaturation at 96°C; 1 min annealing at
58°C and 3 min extension at 72°C. A final extension step
was performed at 72°C for 15 min. PCR products were
purified (QIAquick PCR Purification Kit, Qiagen, Hilden,
Germany) and cloned into a pCR®4-TOPO vector usingthe TOPO TA cloning kit for sequencing (Invitrogen,
Karlsruhe, Germany). Initially, up to 90 clones were se-
quenced per individual to detect the saturation threshold.
The relationship between the number of different MHC
alleles in relation to the number of sequenced clones per
individual indicated that the saturation plateau was
reached after 20-25 clones in most of the individuals
(Figures not shown). As a conservative approach, 40 re-
combinant clones per individual were selected and ampli-
fied using the vector primers T7 and M13 rev. Cloned
PCR products were purified and sequenced directly on an
A3130xl automated sequencer using the BigDye Termin-
ator v3.1 Cycle Sequencing Kit (both Applied Biosystems
Deutschland GmbH, Darmstadt, Germany).
The criteria used to define a sequence from cloning/
Sanger sequencing as a true MHC allele were based on
its occurrence in at least two independent PCR reactions
derived from the same or different individuals. Allele se-
quences were named according to the nomenclature
rules set by Klein et al. [36].
NGS approach: laboratory procedures for 454
pyrosequencing
In order to facilitate PCR error and bias recognition, all in-
dividuals (N = 40) were amplified twice in independent
PCRs (referred to as amplicon replicates), i.e. each individ-
ual was included twice on the 454 plate using different
barcoding tag combinations. For library preparation we
used fusion primers consisting of four parts (Additional
file 1: Figure S1). At the 5’ end the primers contain an
adaptor sequence (forward adaptor A: CGTATCGCCTC
CCTCGCGCCA, reverse adaptor B: CTATGCGCCTT
GCCAGCCCGC), followed by an internal library key
(TCAG). A combination of barcodes sequences recom-
mended by Roche, the so-called multiplex identifiers
(MIDs, 10 bp long), were used to identify each amplicon
replicate. For each direction a set of nine different MIDs
differing in at least 3 positions from each other was
chosen (f-MID, r-MID). The 9 forward and 9 reverse
MIDs produce 81 possible combinations, and allowed
us to pool and distinguish 80 different samples (two
PCR replicates for each of the 40 individuals) in one sin-
gle 454 region by using only 18 different fusion primers.
The DRB-specific amplification primers were the same
as the ones used for cloning (JF8-iV, Tub2JF) and
formed the last part of the fusion primers (Additional
file 1: Figure S1).
PCR was carried out in 25 μL reaction volumes
containing 0.4 μM of each fusion primer, 0.2 mM dNTPs,
2.5 μL FastStart buffer and 1.25 U FastStart HiFi Polymer-
ase (Roche Diagnostics GmbH, Grenzach-Wyhlen,
Germany). Reactions comprised an initial denaturation
step at 94°C for 2 min, followed by 35 cycles of 30 sec de-
naturation at 94°C; 30 sec annealing at 58°C, 1 min
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After amplification the PCR products were purified using
the Agencourt AMPure system (Agencourt Bioscience
Corporation, Beverly, MA) and then quantified by the
Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen Cor-
poration). Subsequently, all amplicons were diluted to
200,000 molecules/μl and pooled.
During emulsion PCR (emPCR), the library was clonally
amplified using the GS FLX Titanium SV emPCR Lib-A
kit (Roche Diagnostics GmbH). Following immobilization
onto DNA capture beads, the bead-bound amplicons were
added to the emulsion oil and the amplification reagents.
Through shaking on a Tissue Lyser (Qiagen) each bead is
captured within its own microreactor where PCR amplifi-
cation occurs. EmPCR was dispensed into a 96-well plate
and the PCR program was run according to manufacturer's
instructions. After amplification, the beads were recovered
by emulsion breaking and washed. Using a biotinylated pri-
mer A (complementary to adaptor A), which is bound to
streptavidin-coated magnetic beads, DNA library beads
were enriched. The DNA library beads were then separated
from the magnetic beads by melting the double-stranded
amplification products, leaving a population of bead-bound
single-stranded template DNA fragments, to which the se-
quencing primer was annealed. Then the library pool was
sequenced in one GS FLX Titanium run on 1/8th of a 70 ×
75 PicoTiter plate.Initial 454 data quality check and reads filtering
454 sequencing images and signals were processed with
the Genome Sequencer FLX System Software using the
standard amplicon pipeline option. A definition of all
terms used is provided in Table 1. In order to ensure data
quality and to select reads for subsequent data validation
procedures we used several filtering steps (Figure 1). As
the initial step, all reads substantially shorter (<250 bp)
than the expected length (~290 bp including MIDs, spe-
cific MHC primers and target) were removed. It has to be
noted that at this step potential pseudogenes with struc-
tural abnormalities were lost which might be of interest to
population genetic studies or to comparative genetics.
Subsequently, all remaining reads were sorted based on
their forward and reverse MID, discarding those reads
with incomplete/incorrect MID sequences which could
not be assigned to any individual. From this point onwards
all steps were performed for each independent amplicon
(i.e. each MID combination) separately. Reads were fur-
ther filtered out when showing an incomplete/incorrect
primer region and/or lower quality (less than 95% bases
with Phred quality score > 20). In the last steps we looked
for indels, allowing only multiple of 3 bp indels (corre-
sponding to one amino acid), and selected all reads with
an expected target sequence length. The reads were finallyaligned with Muscle v3.8 [37] using a Python script to
automate the process. The alignments were entered in the
software Geneious Pro v5.5 [38] and a visual inspection
was quickly performed in order to identify possible reads
with changes in the reading frame. A shift in the reading
frame was not accepted because the region analyzed com-
prises a coding exon. All remaining reads were ready for
subsequent allele and artefact identification workflow to
detect potential sequencing errors and PCR artefacts be-
fore the final putative allele calling (Figure 2).Putative MHC alleles and artefacts identification
A workflow consisting of a series of steps (I to III) was de-
veloped for assigning the final reads to putative MHC al-
leles (Figure 2). Each step was performed for all amplicons
across individuals before moving to the next step, and step
III was repeated until all clusters were classified either as
‘putative artefact’, ‘unclassified variant’, or ‘putative allele’.
The first step of this workflow treats each independent
amplicon separately and begins with the assembling of all
identical reads into clusters (step I). All reads not assigned
to clusters (i.e. singletons) were considered as ‘putative ar-
tefacts’ and not included in further analyses as they are
likely a result of PCR or sequencing errors. For the subse-
quent steps all clusters (from now on also called variants
as they represent a specific sequence) were numbered and
organized in hierarchical order based on their frequency
(i.e. Cluster1 as the most frequent). The classification of
variants at the end of step I was done based on an intra-
amplicon evaluation, and assigned the clusters to three
different categories: ‘chimera’, ‘1-2 bp diff ’, ‘> 2 bp diff ’. This
classification was done to facilitate subsequent artefacts
recognition, based on two important assumptions: 1. Arte-
factual sequences generated in vitro are less frequent than
their source(s) (usually true alleles) within an amplicon
and 2. Artefacts should be less frequent within an
amplicon than any true allele. With these assumptions, we
could work with variant frequencies (i.e. percentages
within the amplicon) as the main tool for defining ‘puta-
tive alleles’. According to these assumptions, true MHC
alleles were expected to be amongst the most frequent
clusters in the dataset, although some attention must be
paid for possible amplicons for which primers presented a
sub-optimal efficiency and real MHC alleles might there-
fore appear in lower frequencies.
Chimeras were identified with a dedicated Python script,
which simply tested if the query cluster could be a com-
bination of two different, but more frequent clusters.
Although it could be difficult to differentiate in vitro chi-
meras from true recombinants, we have considered that
chimeras should always be less frequent than the putative
alleles from which they originated, as stated in our as-
sumption number 1 (see above).
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ters (starting with Cluster2) were compared with more fre-
quent ones, in order to identify the most similar variant.
The clusters were assigned to two intra-amplicon categories
when compared to their most similar cluster: either one or
two base pair differences (‘1-2 bp diff ’) or more than two
base pair differences (‘>2 bp diff ’). ‘1-2 bp diff ’ are likely to
be polymerase errors that got amplified during PCR, and
‘>2 bp diff ’ probably represent more complex kinds of arte-
facts that are hard to be defined, such as mosaics of more
than two fragments or chimeras plus polymerase errors
(we have found examples of both kinds). After finalizing
step I for all individuals, all data was organized in a local
PostgreSQL database (http://www.postgresql.org/) in order
to facilitate the subsequent comparisons and to keep all in-
formation organized and promptly available.
The second step (step II) of the workflow (Figure 2)
aims to recognize most of the putative artefacts, by com-
paring both MID combinations (i.e. amplicon replicates)
of each individual, as well as amplicons from different in-
dividuals. It begins with checking for each intra-amplicon
cluster classification the occurrence of a given variant in
the second amplicon. The absence of variants labelled as
‘1-2 bp diff ’ (IIa) or ‘chimera’ (IIc) in the second amplicon
classifies those as ‘putative artefacts’. The same is not true
for ‘>2 bp diff ’, which is classified as ‘putative artefact’ at
this step only if it is not present in any other individual. Fi-
nally, whenever a variant is classified in both amplicons as
a chimera, it is also classified as a ‘putative artefact’ (IIc).
All the ‘putative artefacts’ classified until now will be
used in step III to help defining ‘putative alleles’, based on
their intra-amplicon frequencies. Variants grouped into
the categories ‘1-2 bp diff ’ (IIIa) and ‘>2 bp diff ’ (IIIb)
which were present in both amplicon replicates but less
frequent than any annotated artefact were labelled as ‘un-
classified variants’, since they are not amongst the most
frequent clusters but are unlikely to be artefacts if they ap-
pear in both replicates in at least two copies each (i.e. in
clusters). Those present in both amplicons and more fre-
quent than all annotated artefacts are considered as ‘puta-
tive MHC alleles’ (IIIa, IIIb-1). Variants labelled as ‘>2 bp
diff ’ not detected in the second amplicon were further
checked for presence in other individuals (IIIb-2). If the
variant is considered as a ‘putative allele’ or ‘unclassified’
in another individual it was labelled as ‘unclassified vari-
ant’, otherwise it was considered as a ‘putative artefact’
(IIIb-2). In our analysis, none of the chimeras were
grouped to a different category in the amplicon replicate,
and therefore all were considered as ‘putative artefacts’.
We have, however, designed further classification steps for
those cases where variants do not appear as ‘chimeras’ in
both replicates. In this case, a variant will be assumed to
be a ‘putative allele’ if it is present in other individuals, and
will be considered as a natural recombinant.At the end of step III, all variants are classified either as
‘putative alleles’, ‘putative artefacts’ or ‘unclassified variants’
(Figure 2) for each amplicon in which they occur. Variants
classified as ‘putative alleles’ and/or ‘unclassified’ were fur-
ther evaluated in order to identify alleles with inconsistent
frequencies among amplicons. Variants recognized as ‘pu-
tative alleles’ in some individuals but more frequently
classified as ‘unclassified variants’, because of low fre-
quencies (compared to artefacts) or absence in one of
the individual amplicons, were identified as ‘low fre-
quency putative alleles’.
Alternative ready-to-use tools
Most of our analysis was done without the use of specific-
ally designed software packages. All data were organized
in a PostgreSQL database and analyses were mainly done
with either self-coded Python scripts or SQL queries.
However, there are a number of software packages avail-
able that facilitate following our workflow (Figure 2) with-
out the need of coding. The jMHC software [39] and
SESAME (SEquence Sorter & AMplicon Explorer) [40], for
example, allow 454 filtered data to be separated by barcode
(including 2-sided barcodes) and summarizes all informa-
tion about variables present in one or more amplicons.
Alignments for single amplicons ordered based on variant
frequency can be saved in single files. Visualization of align-
ments for chimera identification may be done with MEGA5
[41] for instance, as well as the construction of pair-wise
sequence comparison matrices, useful to distinguishing
closely related sequences (1-2 bp) from more unrelated
ones (>2 bp). All data originating from jMHC can be
imported in a table format and organized using commonly
available spreadsheet softwares. Any extra information (e.g.
intra-amplicon and inter-amplicon analysis) may be entered
in the same table, which continues to be incremented as
one moves forward throughout our workflow (Figure 2).
Estimation of allele’s amplification efficiency
The reliability of the coverage of genotypes depends on al-
lele amplification efficiencies. We derived a maximum
likelihood optimization approach allowing the estimation
of the relative amplification efficiency of each allele. Im-
portantly, this method assumes that each allele can be
characterized by a single efficiency value i.e. that the amp-
lification efficiency of a given allele is 1) independent from
the genotype and 2) similar among PCR samples with
identical conditions. The method uses the density function
of the multinomial distribution that provides the probabil-
ity of an event that would have led to the number of reads
observed for a given amplicon and for a given set of ampli-
fication efficiency values. Multiplying the probabilities as-
sociated with each amplicon over the entire dataset (or
summing them on a log-scale), one can therefore obtain
the (log)likelihood of the data given the amplification
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tion of the amplification efficiency of each allele, one can
estimate the amplification efficiencies maximizing this
function using an optimization algorithm. It provides
amplification efficiency values that are the most likely to
have resulted to the observed dataset. The method has
been implemented in the language R [42], a free open
source statistical program, and the script is provided and
detailed in additional material (Additional file 4: R-Codes).
The estimated amplification efficiencies obtained by
this process are relative values. Consequently, we then
estimated the standardised amplification efficiency for
each MHC allele using the amplification efficiency of
MHC allele Desu-DRB*001 (Additional file 1: Figure S2,
Additional file 2: Table S2) as reference, i.e. considering
its standardised amplification efficiency to be one. This
allele was chosen as the reference because the MHC for-
ward primer was developed based on the DNA sequence
of a longer fragment obtained originally with a pair of
degenerated primers and that corresponds to Desu-
DRB*001. The reverse primer used in this study remained
degenerated. To obtain standardised amplification effi-
ciency values, we therefore recomputed the amplification
efficiency of other alleles by dividing their relative amplifi-
cation efficiency by the efficiency of the reference allele.
Importantly, this standardization is necessary for identify-
ing potentially duplicated alleles (i.e. those with a stan-
dardised efficiency ≥ 2) but it plays no role in the study of
the variation in amplification efficiency between alleles,
nor for coverage analyses described below.
Estimation of the minimum number of reads
needed-estimation of Galan’s T1 considering equal
and different allele amplification efficiencies
To compare the minimum number of reads needed to
reach a certain coverage under the assumption of equal
amplification efficiencies between alleles (T1Galan Simul) and
taking variation in amplification efficiency into account
(T1Simul VarAmplEff ), we used a simulation approach based
on random drawings in a multinomial distribution. In both
conditions, we estimated for each genotype the minimum
number of reads so that all alleles were represented by at
least two reads in 99.9% of 10,000 simulations. We repli-
cated the estimation of T1 100 times for each genotype and
took the median values to generate T1Galan Simul and T1Simul
VarAmplEff (Additional file 4: R-Codes).
To evaluate our previous assumption that the amplifica-
tion efficiency of a given allele is independent from the in-
dividual and genotype, we allowed each allele to have a
different probability in different amplicons. To do so, we
used the allele frequencies observed in each amplicon as
the expected amplification efficiencies (i.e. number of
reads representing one allele divided by the sum of all
reads representing alleles in one single amplicon). Wesimulated the distribution of the number of reads among
alleles for each genotype by performing a random sam-
pling with replacement of the observed reads and estimat-
ing T1Resampled as the number of reads sampled required
for reaching the threshold for genotype coverage. For each
genotype we performed 1000 simulations per number of
reads and T1Resampled was estimated as the lower number
of simulated reads which identified all putative alleles in at
least 99.9% out of the 1,000 simulations. Again, this com-
putation was performed 100 times for each genotype and
the median of the T1Resampled values was retained. The en-
tire procedure was performed on both amplicon replicates
of each individual. The dedicated R script is provided in
the Additional file 4: R-Codes.
Finally, we estimated the required number of reads for
different values of minimal amplification efficiency and
number of alleles. To do so, we simulated number of reads
for a given number of alleles by assuming that the amplifi-
cation efficiency of all but one allele is equal to one. For
the remaining alleles, we set the amplification efficiency to
the minimum value investigated and considered for this
latter all values between 0.01 and 1. T1 was computed 100
times for each number of alleles and minimum amplifica-
tion efficiency and 10,000 sets of reads were simulated for
each run. The final T1 value considered was again the me-
dian value among the 100 T1 values computed for each
combination of number of alleles and minimum amplifica-
tion efficiency.Additional files
Additional file 1: Figure S1. Describes the fusion primers and barcode
combinations for 454 library preparation. Figure S2 contains an
alignment of amino acid sequences of D. sublineatus MHC class II DRB
alleles detected by cloning/Sanger sequencing and/or 454
pyrosequencing and outlines antigen-binding sites [43]. Figure S3 shows
the allele frequencies in individuals genotyped by cloning/Sanger
sequencing and 454 pyrosequencing. Figure S4 indicates the
comparison of levels of individual MHC class II DRB diversity obtained by
conventional cloning/Sanger sequencing and next-generation 454
pyrosequencing. Figure S5 outlines the predicted minimum number of
reads (T1Min Amp Eff) required to determine a complete genotype for at
least two reads per allele (99.9% confidence level). Figure S6 shows the
same as Figure S5 but for at least three reads per allele.
Additional file 2: Table S1. Shows the MHC-DRB diversity in
D. sublineatus detected by cloning/Sanger sequencing and 454
pyrosequencing using the identical individuals. Table S2 shows a list of
the standardised allele amplification efficiencies. Table S3 shows the
predicted minimum number of reads necessary to obtain at least two
reads per allele based on minimum amplification efficiency. Table S4
shows the predicted minimum number of reads necessary to obtain at
least three reads per allele based on minimum amplification efficiency.
Additional file 3: Text S1. Describes possible adjustments of the reads
filtering pathway (Figure 1) and our allele and artefact identification
workflow (Figure 2) to different needs in forthcoming MHC studies.
Additional file 4: The R-Codes used to estimate the allele’s
amplification efficiency and the different T1 thresholds.
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